PGY2 Oncology

• The Fred & Pamela Buffett Cancer Center – Nebraska Medical Center is nationally respected and one of the founding members of the National Comprehensive Cancer Network (NCCN). 
• The Fred & Pamela Buffett Cancer Center, an entity of Nebraska Medicine and UNMC, integrates research and education with patient care to offer the most up-to-date treatments for a variety of cancers.
• A unique collaboration between Nebraska Medicine cancer physicians and UNMC researchers allows discoveries made in the laboratories to be taken directly to the patient.
• We are recognized internationally for pioneering autologous transplantation for lymphoma, using peripheral stem cells as an alternative rescue product, conducting groundbreaking studies on various growth factors and performing transplants in alternate settings other than traditional inpatient hospital units. 
• The outpatient transplant program employs a care model that allows patients and their care partners to play an active role in the treatment and recovery process following cancer care.   

Required Rotations

Orientation (July – 4 weeks) 
BMT/Leukemia/Cellular Therapy (6 weeks) 
Medical Oncology/Hematology (4 weeks) 
Pediatric Hematology/Oncology (4 weeks) 
Infusion Center (4 weeks) 
Gynecology Oncology Inpatient/Clinic (2 weeks) 
Ambulatory Oncology Clinic – Heme/BMT (4 weeks) 
Ambulatory Oncology Clinic – Solid Tumors (4 weeks) 
Specialty Pharmacy (2 weeks) 
Oncology Infectious Diseases (2 weeks) 

Elective Rotations

Pain Management/Palliative Care (2 to 4 weeks) 
Disease- Specific Ambulatory Clinic (2 to 4 weeks) 
Transitions of Care (4 weeks) 
Benign Hematology (2 to 4 weeks)
BMT/Leukemia/Cellular Therapy (2 to 4 weeks)
Medical Oncology/Hematology (2 to 4 weeks)
Infusion Center (2 to 4 weeks)

Longitudinal Rotations

Oncology Pharmacy Management (52 weeks with a 2-week focused experience, July through June) 
Drug Policy/Formulary Management (52 weeks, July through June) 
Research (52 weeks, July through June) 
Oncology Residency Conference/Teaching (52 weeks, July through June) 
Investigational Drug Service (52 weeks, July through June) 
Ambulatory Oncology Clinic (Solid and Heme/BMT) (48 weeks, August through June, a half-day weekly) 
Leadership Development Series (if not completed during PGY1 year, 52 weeks, July through June) 

PGY2 residents are required to fulfill the service commitment (staffing) designed to ensure that residents gain experience and can function as competent clinical oncology practitioners. Each resident will train with preceptors, and basic training will take place during the first month of residency.  

As part of the service commitment for PGY2 residents, the following staffing requirements apply: 

1. PGY2 oncology residents will staff 22 shifts throughout the year, approximately two weekday evening shifts per month and every eighth weekend, covering a day shift. 
2. PGY2 oncology residents must work one holiday. 
3. Staffing will occur in the C.L. Werner Cancer Hospital Oncology-Hematology Special Care Unit.
    

Jared Matya, PharmD, BCOP 
Clinical Pharmacist Practitioner – Blood and Marrow Transplant 
PGY2 Oncology Residency Program Director 
Nebraska Medicine 
981090 Nebraska Medical Center 
Omaha, NE 68198-1090 
Phone:  402.552.3929 

Email Jared Matya 

Ashley Kenkel, PharmD, BCOP 
Oncology Ambulatory Care Pharmacist
PGY2 Oncology Assistant Residency Program Director 
Nebraska Medicine 
981090 Nebraska Medical Center 
Omaha, NE 68198-1090
Phone: 402.552.3929

Email Ashley Kenkel